Keyphrases
Transient Middle Cerebral Artery Occlusion (tMCAO)
100%
Angiogenesis
100%
Neuroprotection
100%
Rat Model
100%
Hypoxia-inducible factor-1α (HIF-1α)
100%
Fluoxetine
100%
Netrin
100%
Protein Expression
27%
Ischemic Stroke
18%
Ischemia
9%
Functional Recovery
9%
Synchrotron Radiation
9%
Optical Microangiography
9%
Promising Drug
9%
Vascular Endothelial Growth Factor Receptor (VEGFR)
9%
Neurological Deficit
9%
Neurobehavioral Tests
9%
Brain Atrophy
9%
Infarct Volume
9%
Ischemic Brain
9%
Infarct Size
9%
Synchrotron Radiation Angiography
9%
Clinical Outcomes
9%
Neuroscience
Neuroprotection
100%
Fluoxetine
100%
Vascular Endothelial Growth Factor
100%
Middle Cerebral Artery
100%
Angiogenesis
100%
Netrin
100%
Protein Expression
27%
In Vivo
18%
Synchrotron Radiation
18%
Brain Ischemia
18%
Netrin Receptor DCC
9%
Receptor
9%
Ischemia
9%
Angiography
9%
Pharmacology, Toxicology and Pharmaceutical Science
Rat Model
100%
Neuroprotection
100%
Vasculotropin
100%
Fluoxetine
100%
Middle Cerebral Artery Occlusion
100%
Netrin
100%
Brain Ischemia
18%
Infarction
18%
Synchrotron Radiation
18%
Brain Atrophy
9%
Receptor
9%
Ischemia
9%
Netrin Receptor DCC
9%